iRadimed is on the Move, Heres Why the Trend Could be Sustainable

IRMD Stock  USD 52.75  0.83  1.55%   
About 67% of Iradimed's investor base is looking to short. The analysis of overall sentiment of trading Iradimed Co stock suggests that many investors are alarmed at this time. The current market sentiment, together with Iradimed's historical and current headlines, can help investors time the market. In addition, many technical investors use Iradimed stock news signals to limit their universe of possible portfolio assets.
  
iRadimed made it through our Recent Price Strength screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Read at finance.yahoo.com
Yahoo News
  

Iradimed Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Iradimed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Iradimed Fundamental Analysis

We analyze Iradimed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Iradimed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Iradimed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Iradimed is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Iradimed Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Iradimed stock to make a market-neutral strategy. Peer analysis of Iradimed could also be used in its relative valuation, which is a method of valuing Iradimed by comparing valuation metrics with similar companies.

Peers

Iradimed Related Equities

ANIKAnika Therapeutics   3.02   
0%
88.0%
LUNGPulmonx Corp   2.54   
0%
74.0%
KIDSOrthopediatrics Corp   2.05   
0%
60.0%
ELMDElectromed   1.87   
0%
54.0%
SGHTSight Sciences   1.79   
0%
52.0%
ITGRInteger Holdings   1.46   
0%
42.0%
GKOSGlaukos Corp   1.39   
0%
40.0%
OFIXOrthofix Medical   1.10   
0%
32.0%
SRDXSurModics   0.10   
2.0%
0%
NPCENeuropace   0.49   
14.0%
0%
CNMDCONMED   0.99   
29.0%
0%
LIVNLivaNova PLC   3.41   
100.0%
0%

Complementary Tools for Iradimed Stock analysis

When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format